When: Closing break of 50 SMA at $358.81 on volume >7M shares

Then: Automatic downgrade to Underweight with 15-20% trim; stop on residual at $348

When: Sustained close above $387 on volume >8M with MACD extension

Then: Starter add of 25-30% with stop at the 50 SMA

HOLD

• RSI cooling from 70 to 60 is NOT bearish divergence; price made a lower high at 384.14 on August 25 with RSI at 70.6, now at 378.40 with RSI at 60.2; both declining together is normal pullback after rally, not divergence or rollover
• Visa returned over 100% of net income to shareholders last year through buybacks and dividends combined; this is the point of owning a network business with minimal capex needs, not financial engineering
• V has beta of 0.76 (below market); concentration risk is driven by correlation and volatility, not position size alone; a 6% position in low-beta quality compounder carries less portfolio risk than 3% in high-beta name
• DOJ overhang is already priced in; stock has lagged the Dow for a year; trial not until 2028 means years of compounding at underlying growth rate while waiting; overhang is argument for HOLD, not SELL
• Redeploy capital toward better setups is dangerous with no alternatives identified; selling high-quality low-beta compounder for unnamed opportunities is performance-chasing in reverse
• Stop at 388 is 2.6% above entry with ATR at 6.77, less than half an ATR of breathing room; almost guaranteed whipsaw in stock that bounced 1.5% off 10 EMA with 50 SMA 5% below
• Alternative proposal: HOLD full position, set wider trailing stop at 368-370 (50 SMA area, roughly 1.4 ATR below current price) to allow normal volatility breathing room; trim only if closes below 368
• If V consolidates between 370-385, collect dividend and let buybacks work; if breaks above 387, re-evaluate adding, not trimming; manage concentration through future allocation decisions

→ vs aggressive: RSI cooling from 70 to 60 is called 'textbook negative momentum divergence' but this is incorrect framing; real bearish divergence requires price making higher high while momentum makes lower high; here both price and momentum declined, which is normal pullback not divergence

→ vs aggressive: Buybacks called 'financial engineering' masking weak organic growth reveals misunderstanding of mature compounder mechanics; returning 100%+ of net income to shareholders is the point of owning network business with minimal capex, not a red flag

→ vs aggressive: Concentration at 5-7% called 'meaningful' but ignores V's beta of 0.76; concentration risk is driven by correlation and volatility not just position size; solution requires gradual rebalancing over quarters not tactical selling into 1.5% bounce

→ vs aggressive: DOJ overhang called 'structural ceiling on multiple expansion' and reason to sell; but overhang is already priced in given year of Dow underperformance; trial not until 2028 means years of compounding; this is argument for HOLD not SELL

→ vs aggressive: Redeploy capital toward better setups is most dangerous part of proposal; no single better opportunity identified; this is performance-chasing in reverse that historically destroys value more often than creates it; selling at 378 to wait for 345-355 pullback risks missing compounding if V grinds sideways or higher

→ vs aggressive: Stop at 388 on retained position creates almost guaranteed whipsaw; 2.6% above entry with ATR at 6.77 is less than half ATR breathing room; would sell at 378, get stopped out at 390, and watch stock continue to 410; average sale below ultimate price

Trim 15% of position with stop at $378 on retained shares; define redeployment criteria before selling

• Price at 378.40 with RSI at 60.24; prior high of 384.14 with RSI at 70.6 - both price and RSI pulling back together from overbought, not bearish divergence
• ATR compressed to 6.77 from 8.5 - coiled setup suggesting directional move coming, direction uncertain
• 6% position in 0.76 beta name still carries meaningful concentration risk; 15% drawdown would be 0.9% portfolio impact
• DOJ overhang likely already priced in as V has lagged Dow for 12 months; selling here means selling at bottom of overhang discount range
• Aggressive $388 stop is too tight (0.5 ATR of breathing room) and will likely get whipsawed on first test of Bollinger upper at 386.94
• Conservative $368-$370 trailing stop is too loose and gives back most of the move from $360 to $378
• Buyback-driven EPS growth creates structural dependence on management continuing buybacks at current pace - not a sell signal but a reason to take some chips off
• Recommend trim of 15% (not aggressive's 25-35%) to address concentration while preserving core thesis
• Set stop at $378 itself - daily close below trim price signals uptrend broken
• Must define redeployment triggers: V pullback to $370 area with RSI at 50 or below, OR break above $387 on volume
• Core thesis remains intact: defensive compounder with elite fundamentals, Ackman position, Goldman institutional flow, Fed-on-hold backdrop

→ vs aggressive: Divergence argument is weak - real bearish divergence requires price making higher high while RSI makes lower high; here both pulled back together from overbought, textbook healthy cooling not rollover

→ vs aggressive: $388 stop is too tight at 0.5 ATR of breathing room; will get stopped out on first test of Bollinger upper at 386.94

→ vs conservative: Treating any cooling as benign understates risk - ATR compression signals coiled move coming, prudent to reduce exposure before volatility re-expands

→ vs conservative: 6% low-beta position still carries concentration risk - 15% drawdown equals 0.9% portfolio impact; gradual rebalancing without tactical trim means riding position all the way down if it breaks

→ vs conservative: $368-$370 trailing stop is too loose and gives back most of the $18 move from $360 to $378

→ vs conservative: Beta argument doesn't fully refute concentration concern - concentration risk and volatility risk are related but not identical